FDA Drugs (New Approvals & NDA)Original article
Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations - 10/14/2026
ConferenceNeutral
AI Analysis
Summary
The FDA is holding an event on 10/14/2026 on its Bayesian draft guidance, covering design, analysis, and review considerations. The event is aimed at clinical trial, regulatory science, and regulatory affairs professionals working on studies where Bayesian approaches may be used.
Importance:2/10
Sentiment:
0.00
FDABayesian statisticsdraft guidanceclinical trial designregulatory scienceeducational event
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 15, 2026 5:56 PM